CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(09): 625-630
DOI: 10.1590/0004-282X20170101
ARTICLES

How often should sitting and rising from a chair be evaluated in patients with Duchenne muscular dystrophy?

Com que frequência deve ser avaliada a atividade de sentar e levantar da cadeira em pacientes com distrofia muscular de Duchenne?
Michele Emy Hukuda
1   Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisioterapia e Comportamento, São Paulo SP, Brasil;
,
Fátima Aparecida Caromano
1   Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisioterapia e Comportamento, São Paulo SP, Brasil;
,
Renata Escorcio
1   Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisioterapia e Comportamento, São Paulo SP, Brasil;
,
Eduardo Vital de Carvalho
1   Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisioterapia e Comportamento, São Paulo SP, Brasil;
,
Silvana Maria Blascovi-Assis
2   Universidade Mackenzie, Faculdade de Fisioterapia, São Paulo SP, Brasil.
,
Mariana Callil Voos
1   Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisioterapia e Comportamento, São Paulo SP, Brasil;
› Author Affiliations

ABSTRACT

Objective To determine how often sitting/rising from a chair should be assessed in Duchenne muscular dystrophy (DMD) patients to avoid redundant/missing data.

Methods Sitting/rising from a chair was evaluated in 26 DMD children (5-12 yrs), in three-month intervals, over twelve months, with the Functional Evaluation Scale (domain sitting/rising from a chair). Scores were compared by effect sizes (ES) and standardized response means (SRM) (responsiveness analysis).

Results Sit-to-stand showed low-to-moderate responsiveness in three-month intervals (ES:0.23-0.32; SRM:0.36-0.68), moderate-to-high responsiveness in six-month intervals (ES:0.52-0.65; SRM:0.76-1.28), high responsiveness at nine-month (ES:0.84-0.91; SRM:1.26-1.64) and twelve-month intervals (ES:1.27; SRM:1.48). Stand-to-sit showed low responsiveness in three-month intervals (ES:0.26-0.49; SRM:0.37-0.42), moderate responsiveness in six-month intervals (ES:0.50-0.78; SRM:0.56-0.71), high responsiveness in nine-month (ES:0.94-1.00; SRM:0.84-1.02) and twelve-month intervals (ES:1.13; SRM:1.52).

Conclusion Six months or longer intervals for reassessment are indicated to evaluate sitting/standing from a chair in DMD patients.

RESUMO

Objetivo Determinar a frequência de avaliação do sentar e levantar da cadeira em pacientes com distrofia muscular de Duchenne (DMD), para evitar informações faltantes ou redundantes.

Métodos Sentar/ Levantar foram avaliados em 26 crianças com DMD (5-12 anos), em intervalos de três meses, durante doze meses, com a Escala de Avaliação Funcional (domínio sentar/ levantar da cadeira). Os tamanhos do efeito (TE) e as médias de resposta padronizada (MRP) foram usados na análise de responsividade.

Resultados Levantar da cadeira teve responsividade baixa a moderada em três meses (TE: 0,23-0,32; MRP: 0,36-0,68), moderada a alta em seis meses (TE: 0,52-0,65; MRP: 0,76-1,28), alta em nove e (TE: 0,84-0,91; MRP: 1,26-1,64) doze meses (TE: 1,27; MRP: 1,48). Sentar na cadeira teve responsividade baixa em três meses (TE: 0,26-0,49; MRP: 0,37-0,42), moderada em seis meses (TE: 0,50-0,78; MRP: 0,56-0,71), alta em nove (TE: 0,94-1,00; MRP: 0,84-1,02) e doze meses (TE: 1,13; MRP: 1,52).

Conclusão Os pacientes com DMD devem ser reavaliados com intervalos mínimos de seis meses entre avaliações de sentar/ levantar da cadeira.



Publication History

Received: 15 May 2017

Accepted: 16 May 2017

Article published online:
05 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77-93. https://doi.org/10.1016/S1474-4422
  • 2 Vuillerot C, Payan C, Girardot F, Fermanian J, Iwaz J, Bérard C et al. Responsiveness of the motor function measure in neuromuscular diseases. Arch Phys Med Rehabil. 2012;93(12):2251-6.e1. https://doi.org/10.1016/j.apmr.2012.05.025
  • 3 Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186-97. https://doi.org/10.1002/mus.880040304
  • 4 Vignos PJ, Spencer GE, Archibald KC. Management of progressive muscular dystrophy in childhood. JAMA. 1963;184(2):89-96. https://doi.org/10.1001/jama.1963.03700150043007
  • 5 Vuillerot C, Girardot F, Payan C, Fermanian J, Iwaz J, De Lattre C et al. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with Motor Function Measure. Dev Med Child Neurol. 2010;52(1):60-5. https://doi.org/10.1111/j.1469-8749.2009.03316.x
  • 6 Martini J, Voos MC, Hukuda ME, Resende MB, Caromano FA. Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2014;72(1):5-11. https://doi.org/10.1590/0004-282X20130196
  • 7 Hukuda ME, Escorcio R, Fernandes LA, Carvalho EV, Caromano FA. Evaluation scale development, reliability for sitting and standing from the chair for Duchenne muscular dystrophy. J Mot Behav. 2013;45(2):117-26. https://doi.org/10.1080/00222895.2012.760513
  • 8 Carvalho EV, Hukuda ME, Escorcio R, Voos MC, Caromano FA. Development and reliability of the functional evaluation scale for Duchenne muscular dystrophy, Gait domain: a pilot study. Physiother Res Int. 2015;20(3):135-46. https://doi.org/10.1002/pri.1605
  • 9 Fernandes LAY, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV. Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26. https://doi.org/10.1590/S1413-35552010000600011
  • 10 Escorcio R, Caromano FA, Hukuda ME, Fernandes LAY. Development of an evaluation scale for sitting and standing from the ground for children with Duchenne muscular dystrophy. J Mot Behav. 2011;43(1):31-6. https://doi.org/10.1080/00222895.2010.530306
  • 11 Albuquerque PS. Development of software for application of functional scale of people with Duchenne muscular dystrophy and usability testing [thesis]. São Paulo: Universidade de São Paulo; 2013.
  • 12 Nadeau SM, Boukadida A, Piotte F, Mesure S. Weight-bearing perception during standing and sit-to-stand tasks in subacute post-stroke individuals undergoing intensive rehabilitation. Ann Phys Rehabil Med. 2016;59 Suppl:e71-2. https://doi.org/10.1016/j.rehab.2016.07.166
  • 13 Lee G, An S, Lee Y, Park DS. Clinical measures as valid predictors and discriminators of the level of community ambulation of hemiparetic stroke survivors. J Phys Ther Sci. 2016;28(8):2184-9. https://doi.org/10.1589/jpts.28.2184
  • 14 Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L et al. Can quantitative muscle strength and functional motor ability differentiate the influence of age and corticosteroids in ambulatory boys with Duchenne muscular dystrophy?. PLoS Curr. 2016 Jul 8. Edition 1. https://doi.org/10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0.
  • 15 Scrivener K, Schurr K, Sherrington C. Responsiveness of the ten-metre walk test, Step Test and Motor Assessment Scale in inpatient care after stroke. BMC Neurol. 2014;14(1):129. https://doi.org/10.1186/1471-2377-14-129
  • 16 Vuillerot C, Payan C, Iwaz J, Ecochard R, Bérard C. Responsiveness of the Motor Function Measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil. 2013;94(8):1555-61. https://doi.org/10.1016/j.apmr.2013.01.014
  • 17 Allard L, Rode G, Jacquin-Courtois S, Pouget MC, Rippert P, Hamroun D et al. The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease. Ann Phys Rehabil Med. 2014;57(9-10):587-99. https://doi.org/10.1016/j.rehab.2014.09.005
  • 18 Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A et al. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1046-52. https://doi.org/10.1111/dmcn.12220
  • 19 De Groot IJ, Post MW, Van Heuveln T, Van Den Berg LH, Lindeman E. Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index. Amyotroph Lateral Scler. 2006;7(3):167-72. https://doi.org/10.1080/14660820600640620
  • 20 Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(3 Suppl):178-89. https://doi.org/10.1097/00005650-198903001-00015
  • 21 Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care. 1990;2(7)8:632-42. https://doi.org/10.1097/00005650-199007000-00008
  • 22 Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Earlbaum; 1988.
  • 23 Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39(4):475-81. https://doi.org/10.1212/WNL.39.4.475
  • 24 Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V et al. Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1038-45. https://doi.org/10.1111/dmcn.12213
  • 25 Stucki G, Liang MH, Fossel AH, Katz JN. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol. 1995;48(11):1369-78. https://doi.org/10.1016/0895-4356(95)00054-2
  • 26 Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke. Arch Phys Med Rehabil. 2007;88(10):1314-9. https://doi.org/10.1016/j.apmr.2007.06.764
  • 27 Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15(2):141-55. https://doi.org/10.2165/00019053-199915020-00003
  • 28 Cano SJ, O’Connor RJ, Thompson AJ, Hobart JC. Exploring disability rating scale responsiveness II: do more response options help?. Neurology. 2006;67(11):2056-9. https://doi.org/10.1212/01.wnl.0000247664.97643.e8
  • 29 Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL. Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire. Neuromuscul Disord. 2009;19(2):99-103. https://doi.org/10.1016/j.nmd.2008.11.004